Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2013 | 02-2013 | 11-2012 | 08-2012 | 05-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 18,227 | 13,435 | 4,463 | N/A |
| Depreciation Amortization | N/A | 5,527 | 3,661 | 1,856 | N/A |
| Income taxes - deferred | N/A | 4,230 | 3,039 | 1,942 | N/A |
| Accounts receivable | N/A | -5,305 | -8,634 | 1,711 | N/A |
| Accounts payable and accrued liabilities | N/A | 4,511 | 2,949 | 3,837 | N/A |
| Other Working Capital | N/A | -2,848 | -7,603 | 1,097 | N/A |
| Other Operating Activity | 0 | -10,867 | -4,463 | -9,821 | 0 |
| Operating Cash Flow | $N/A | $13,475 | $2,384 | $5,085 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -3,790 | -1,959 | -756 | N/A |
| PPE Investments | N/A | -4,538 | -3,280 | -2,029 | N/A |
| Investing Cash Flow | $N/A | $-8,328 | $-5,239 | $-2,785 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -4,476 | -3,090 | -1,369 | N/A |
| Common Stock Issued | N/A | 1,385 | 651 | 202 | N/A |
| Other Financing Activity | 0 | -14,290 | -12,027 | -13,261 | 0 |
| Financing Cash Flow | $N/A | $-17,381 | $-14,466 | $-14,428 | $N/A |
| Beginning Cash Position | N/A | 22,177 | 22,177 | 22,177 | N/A |
| End Cash Position | N/A | 9,943 | 4,856 | 10,049 | N/A |
| Net Cash Flow | $N/A | $-12,234 | $-17,321 | $-12,128 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 13,475 | 2,384 | 5,085 | N/A |
| Capital Expenditure | N/A | -4,538 | -3,280 | -2,029 | N/A |
| Free Cash Flow | 0 | 8,937 | -896 | 3,056 | 0 |